Among 47 patients with any of several forms of idiopathic inflammatory myositis (IIM) who took efgartigimod (Vyvgart Hytrulo) ...

May 29, 2025Roivant Sciences Ltd. misses on earnings expectations. Reported EPS is $-0.22 EPS, expectations were $-0.16. Operator: Good day, and welcome to the Roivant Fourth Quarter 2024 Earnings ...

Columnist Desiree Lama pens an open letter to her present-day self, who is in need of some support and encouragement while ...

MS is marked by chronic inflammation and demyelination in the central nervous system. Demyelination is the process in which ...

A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says ...

Though considered a rare disease, CIDP affects between 1 to 7 adults per 100,000 and approximately 1 in 200,000 children, with many experts suspecting underdiagnosis and misdiagnosis still plague ...

"EC approves argenx’s efgartigimod alfa for CIDP treatment" was originally created and published by Pharmaceutical Technology ...

New research by Sumeda Nandadasa, Ph.D., reveals how a key protein associated with Meckel-Gruber syndrome, nephronophthisis, ...

People with multiple sclerosis (MS) often face higher unemployment rates. Understanding the available support can help you navigate employment and financial stability.

Panelists discuss exciting phase 3 trial data on a novel selective phosphodiesterase inhibitor that elevates intracellular ...